CD56 is a membrane glycoprotein with prominent roles in cell–cell adhesion [34] and the loss of CD56 expression has been correlated with tumor progression and poor prognosis in patients with some malignant tumors, including PTC [35]. This evidence concerns the gene NCAM1 and neoplasm.